Company Results (links open in a new window)
|
Date (document was filed at Companies House)
|
Type
|
Description (of the document filed at Companies House)
|
View / Download (PDF file, link opens in new window)
|
|
07 Nov 2023 |
PSC05 |
Change of details for Haleon Uk Services Limited as a person with significant control on 18 July 2022
|
|
|
16 Aug 2023 |
AA |
Full accounts made up to 31 December 2022
|
|
|
16 Jun 2023 |
CERTNM |
Company name changed glaxosmithkline consumer healthcare finance no. 2 LIMITED\certificate issued on 16/06/23
-
NM01 ‐
Change of name by resolution
-
RES15 ‐
Change company name resolution on 2023-06-06
|
|
|
05 Jun 2023 |
PSC05 |
Change of details for Haleon Uk Services Limited as a person with significant control on 18 July 2022
|
|
|
05 Jun 2023 |
CH02 |
Director's details changed for Haleon Uk Corporate Secretary Limited on 18 July 2022
|
|
|
05 Jun 2023 |
CH02 |
Director's details changed for Haleon Uk Corporate Director Limited on 18 July 2022
|
|
|
05 Jun 2023 |
CH04 |
Secretary's details changed for Haleon Uk Corporate Secretary Limited on 18 July 2022
|
|
|
30 May 2023 |
CS01 |
Confirmation statement made on 24 May 2023 with updates
|
|
|
17 May 2023 |
CH02 |
Director's details changed for Gsk Consumer Healthcare Holdings No.8 Limited on 31 March 2023
|
|
|
17 May 2023 |
CH04 |
Secretary's details changed for Gsk Consumer Healthcare Holdings No.8 Limited on 31 March 2023
|
|
|
17 May 2023 |
CH02 |
Director's details changed for Gsk Consumer Healthcare Holdings No.4 Limited on 31 March 2023
|
|
|
25 Nov 2022 |
PSC05 |
Change of details for Glaxosmithkline Consumer Healthcare (Overseas) Limited as a person with significant control on 18 November 2022
|
|
|
17 Nov 2022 |
CH01 |
Director's details changed for Mr Michael John Rowe on 18 July 2022
|
|
|
03 Oct 2022 |
AA |
Full accounts made up to 31 December 2021
|
|
|
18 Jul 2022 |
AD01 |
Registered office address changed from 980 Great West Road Brentford Middlesex TW8 9GS United Kingdom to Building 5, First Floor the Heights Weybridge Surrey KT13 0NY on 18 July 2022
|
|
|
24 May 2022 |
CS01 |
Confirmation statement made on 24 May 2022 with no updates
|
|
|
06 Apr 2022 |
TM02 |
Termination of appointment of Edinburgh Pharmaceutical Industries Limited as a secretary on 6 April 2022
|
|
|
06 Apr 2022 |
TM01 |
Termination of appointment of the Wellcome Foundation Limited as a director on 6 April 2022
|
|
|
06 Apr 2022 |
TM01 |
Termination of appointment of Glaxo Group Limited as a director on 6 April 2022
|
|
|
06 Apr 2022 |
AP04 |
Appointment of Gsk Consumer Healthcare Holdings No.8 Limited as a secretary on 6 April 2022
|
|
|
06 Apr 2022 |
AP02 |
Appointment of Gsk Consumer Healthcare Holdings No.8 Limited as a director on 6 April 2022
|
|
|
06 Apr 2022 |
AP02 |
Appointment of Gsk Consumer Healthcare Holdings No.4 Limited as a director on 6 April 2022
|
|
|
09 Mar 2022 |
TM01 |
Termination of appointment of Mariano Jesus Godino Escolar as a director on 4 March 2022
|
|
|
09 Mar 2022 |
TM01 |
Termination of appointment of Nicholas Ian Cooper as a director on 4 March 2022
|
|
|
09 Mar 2022 |
AP01 |
Appointment of Mr Sajid Mehmood as a director on 4 March 2022
|
|